SII starts production of Covid vaccine candidate

Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the US biotech firm's potential Covid-19 vaccine and it expects to begin early-stage human trial by the end of 2020 in the UK. ​Serum Institute, the world's largest vaccine maker by number of doses produced, will develop Codagenix's CDX-005, which is delivered intranasally.